In this issue

Issue 44 • October 2021

Roughly two decades after researchers first unveiled the draft sequence of the human genome, an international team of scientists claim to have successfully mapped 100% of the human genome – identifying more than 100 new genes and millions of genetic variations between humans, some of which could play a role in disease.

While this discovery may be ground-breaking, switching to a full model of the human genome could prove to be a challenge for many clinical labs, which will have to adjust to this new map of human physiology. To find out more, we speak to genomics experts to find out what clinical labs can do to keep up with this research.

Elsewhere in this issue, we examine the hurdles standing in the way of Africa becoming a clinical trial powerhouse, ask why practitioners still refer to the body mass index despite noted criticism of its reliability, and speak to the Hollywood techies who are adding a touch of movie magic to medical devices.

For all this, plus the latest insight and analysis from GlobalData, read on.

Eloise Mclennan, editor

Go to article: Home | Found: the missing 8%Go to article: In this issueGo to article: ContentsGo to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: SiemensGo to article: Apple RubberGo to article: BriefingGo to article: Industry newsGo to article: The medical industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Custom Wire Company Insight Go to article: Custom WireGo to article: Micro Systems TechnologiesGo to article: Repsol Go to article: CommentGo to article: Health tech adoption is toughGo to article: Whole genome sequencing for newborn screeningGo to article: Rates of ransomware attacks continue to rise, impacting mortality ratesGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: In DepthGo to article: Could Africa become a clinical trial powerhouse?Go to article: Keeping up with the human genomeGo to article: Why BMI: healthtech’s ongoing reliance on misleading scienceGo to article: From Marvel to medical: the entertainment techies moving to medtechGo to article: Poor digital communications could be prolonging the Covid-19 pandemicGo to article: EpiShuttle: launching a next-gen patient isolation podGo to article: AccumoldGo to article: PSN LabsGo to article: micrometal Go to article: ElectroCraftGo to article: In DataGo to article: Data: the beginnings of a cloud investment boom?Go to article: The medical industry key listGo to article: Global markets and indicesGo to article: Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next Issue